Viewing Study NCT02785250

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:48 PM
Ignite Modification Date: 2026-02-23 @ 12:21 PM
Study NCT ID: NCT02785250
Status: UNKNOWN
Last Update Posted: 2021-06-18
First Post: 2016-05-18
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Epithelial Ovarian Cancer View
None Recurrent Fallopian Tube Cancer View
None Recurrent Peritoneal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None T cell activation View
None immunotherapy View
None ovarian View
None fallopian tube View
None peritoneal View
None cancer View
None recurrent View
None tumor View
None measurable View